A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants
Clinical trial NCT07777133 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07777133
- Sponsor
- Bristol-Myers Squibb
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-16
- Primary completion
- 2026-12-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.